XOMA
XOMA Corp
NASDAQ: XOMA · HEALTHCARE · BIOTECHNOLOGY
$40.94
-0.12% today
Updated 2026-04-30
Market cap
$497.18M
P/E ratio
28.08
P/S ratio
9.53x
EPS (TTM)
$1.46
Dividend yield
—
52W range
$22 – $43
Volume
0.2M
WallStSmart proprietary scores
52
out of 100
Grade: C
Hold
Investment rating
7.3
Growth
B+5.5
Quality
C+8.0
Profitability
A5.7
Valuation
C+4/9
Piotroski F-Score
Moderate
-6.5
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$62.00
+51.44%
12-Month target
$24.15
-41.01%
Intrinsic (DCF)
$23.79
Margin of safety
+2.19%
0 Strong Buy4 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Profit margin 60.80% — above average
+ ROE 34.10% — strong efficiency
+ Revenue growth 57.90% QoQ
Risks
- Altman Z -6.52 — distress zone
- Negative free cash flow $-5.50M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $6.03M | $4.76M | $28.49M | $52.15M | $52.15M |
| Net income | $-17.10M | $-40.83M | $-13.82M | $31.71M | $6.10M |
| EPS | — | — | — | — | $1.46 |
| Free cash flow | $-36.13M | $-18.18M | $-13.77M | $-17.85M | $-5.50M |
| Profit margin | -283.79% | -858.15% | -48.52% | 60.81% | 60.80% |
Peer comparison
Smart narrative
XOMA Corp trades at $40.94. representing a P/E of 28.08x trailing earnings. Our Smart Value Score of 52/100 indicates the stock is fair. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -6.52, it sits in the distress. TTM revenue stands at $52.15M. with profit margins at 60.80%. Our DCF model estimates intrinsic value at $23.79.
Frequently asked questions
What is XOMA Corp's stock price?
XOMA Corp (XOMA) trades at $40.94.
Is XOMA Corp overvalued?
Smart Value Score 52/100 (Grade C, Hold). DCF value $23.79.
What is the price target of XOMA Corp (XOMA)?
The analyst target price is $62.00, representing +51.4% upside from the current price of $40.94.
What is the intrinsic value of XOMA Corp (XOMA)?
Based on our DCF model, intrinsic value is $23.79, a +2.2% margin of safety versus $40.94.
What is XOMA Corp's revenue?
TTM revenue is $52.15M.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
-6.52 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio9.53x
ROE34.10%
Beta0.68
50D MA$31.60
200D MA$30.99
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.2M
Performance
1 week+3.78%
1 month+35.07%
3 months+65.69%
YTD+53.67%
1 year—
3 years—
5 years—